National Institute for Health and Care Excellence (NICE) Issues Medtech Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac Surgery
- Thursday, February 4, 2021, 7:11
- PR Newswire
- Add a comment
MONMOUTH JUNCTION, N.J., Feb. 4, 2021 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world,…
About the Author
admin has written 20663 stories on this site.